Results 251 to 260 of about 194,657 (287)
Some of the next articles are maybe not open access.

Expression of fibroblast growth factor receptor 3 by fibroblast growth factor 2 in cultured chick embryo chondrocytes

Cell Biology International, 2005
Although fibroblast growth factor 2 (FGF2) and fibroblast growth factor receptor 3 (FGFR3) both inhibit longitudinal bone growth, little is known about the relationship between FGF2 and FGFR3. Accordingly, the current study examined the expression of FGFR3 mRNA after the administration of FGF2 using cultured chondrocytes from day 17 chick embryos to ...
Jo-Young Suh   +4 more
openaire   +3 more sources

p73 and p63 regulate the expression of fibroblast growth factor receptor 3

Biochemical and Biophysical Research Communications, 2010
p53, p63 and p73 make a family of transcription factors that play a vital role in development and cancer. All p53 family members have more than one promoter producing Transactivating (TA) and Dominant Negative (DeltaN) isoforms and their mRNAs are subjected to extensive splicing at 3' end to produce multiple protein products. p53 is usually inactivated
Richard A. Knight   +10 more
openaire   +8 more sources

Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2002
Fibroblast growth factors (FGFs) and their receptors (FGFRs) have been identified in a variety of carcinomas, but there are few studies concerning their presence in oral cancers. The objective of this study was to determine whether FGF-1, FGF-2, and high affinity receptors FGFR2 and FGFR3 are present in the pathogenesis of oral epithelial dysplasias ...
Linda Jackson-Boeters   +3 more
openaire   +3 more sources

Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia

Nature, 1994
Achondroplasia, the most common cause of chondrodysplasia in man (1 in 15,000 live births), is a condition of unknown origin characterized by short-limbed dwarfism and macrocephaly. More than 90% of cases are sporadic and there is an increased paternal age at the time of conception of affected individuals, suggesting that de novo mutations are of ...
Francis Rousseau   +7 more
openaire   +3 more sources

Reduced binding of FGF1 to mutant fibroblast growth factor receptor 3

Growth Factors, 2006
The activating mutation FGFR3-R248C in the D2-D3 linker region of fibroblast growth factor receptor 3 leads as germline mutation to the neonatal lethal syndrome thanatophoric dysplasia type I (TD1). As somatic mutation it has been found in cancer. We introduced into the murine FGFR3 the mutation R242C that is orthologoues to the human mutation R248C. A
Denis Khnykin, Sjur Olsnes
openaire   +3 more sources

Fibroblast growth factor receptor 3 and the human chondrodysplasias

Current Opinion in Pediatrics, 1997
Heterozygous mutations of the gene encoding the fibroblast growth factor receptor 3 (FGFR3) have been found in persons with achondroplasia, thanatophoric dysplasia, and hypochondroplasia. They exhibit considerable genetic homogeneity, and specific mutations strongly correlate with the clinical severity of disease.
openaire   +3 more sources

Fibroblast Growth Factor Receptor-3 as a Marker for Precartilaginous Stem Cells

Clinical Orthopaedics and Related Research, 1999
The epiphyseal organ contains two kinds of cartilage, articular and growth plate. Both enlarge during the growth phase of life. However, mitosis is not apparent in these tissues. In the current study, a search to trace the reservoirs of stem cells needed for the growth of these cartilages is done. A disorder in which the stem cells responsible for bone
Avner Yayon   +5 more
openaire   +3 more sources

Fibroblast Growth Factor Receptor 3 (FGFR3) Expression in Malignant Lymphomas

Applied Immunohistochemistry & Molecular Morphology, 2008
Fibroblast growth factor receptor 3 (FGFR3) protein is aberrantly expressed in approximately 15% of cases of plasma cell myeloma as a result of t(4;14)(p16.3;q32), and FGFR3 expression in myeloma is associated with an adverse prognosis. Novel, recently developed therapeutic agents that target the FGFR3 pathway are currently in clinical trials for ...
Andrew Larson, James R. Cook
openaire   +3 more sources

Generation of Monoclonal Antibody Targeting Fibroblast Growth Factor Receptor 3

Hybridoma, 2009
Fibroblast growth factor receptor 3 (FGFR3) is a member of the FGFR family of receptor tyrosine kinases, whose function has been implicated in diverse biological processes, including cell proliferation, differentiation, survival, and tumorigenesis. Deregulation of FGFR3 signaling has been implicated with human pathologies, including cancer.
Darija Volkova   +7 more
openaire   +3 more sources

Regulation of chondrocyte growth and differentiation by fibroblast growth factor receptor 3.

Novartis Foundation symposium, 2001
Both gain-of-function and loss-of-function mutations in fibroblast growth factor receptor 3 (Fgfr3) have revealed unique roles for this receptor during skeletal development. Loss-of-function alleles of Fgfr3 lead to an increase in the size of the hypertrophic zone, delayed closure of the growth plate and the subsequent overgrowth of long bones. Gain-of-
openaire   +3 more sources

Home - About - Disclaimer - Privacy